DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,033,492 | +4.0% | 197,636 | +0.6% | 0.37% | +8.1% |
| Q2 2023 | $47,165,760 | +95240.2% | 196,524 | +0.1% | 0.35% | -10.6% |
| Q1 2023 | $49,471 | -3.3% | 196,281 | +1.8% | 0.39% | -4.2% |
| Q4 2022 | $51,172 | -99.9% | 192,797 | -3.5% | 0.40% | -8.0% |
| Q3 2022 | $51,592,000 | +2.6% | 199,831 | +0.7% | 0.44% | -0.2% |
| Q2 2022 | $50,292,000 | -10.3% | 198,374 | +3.8% | 0.44% | +11.4% |
| Q1 2022 | $56,080,000 | +1.5% | 191,183 | -1.1% | 0.40% | -4.6% |
| Q4 2021 | $55,262,000 | -8.4% | 193,367 | -2.5% | 0.41% | +13.1% |
| Q3 2021 | $60,350,000 | +12.8% | 198,233 | -0.6% | 0.37% | +9.6% |
| Q2 2021 | $53,520,000 | +8.1% | 199,433 | -9.3% | 0.33% | +6.4% |
| Q1 2021 | $49,500,000 | -33.7% | 219,924 | -34.5% | 0.31% | -34.6% |
| Q4 2020 | $74,615,000 | +42.3% | 335,894 | +37.9% | 0.48% | +13.7% |
| Q3 2020 | $52,436,000 | +23.3% | 243,514 | +1.3% | 0.42% | +7.9% |
| Q2 2020 | $42,513,000 | +32.8% | 240,419 | +3.9% | 0.39% | +9.5% |
| Q1 2020 | $32,020,000 | +4.6% | 231,344 | +16.0% | 0.36% | +36.3% |
| Q4 2019 | $30,615,000 | +5.4% | 199,473 | -0.9% | 0.26% | +1.6% |
| Q3 2019 | $29,060,000 | -4.8% | 201,208 | -5.8% | 0.26% | -11.0% |
| Q2 2019 | $30,511,000 | +16.4% | 213,486 | +7.5% | 0.29% | +13.7% |
| Q1 2019 | $26,209,000 | +29.9% | 198,523 | +1.5% | 0.26% | +13.3% |
| Q4 2018 | $20,171,000 | +2.1% | 195,606 | +7.6% | 0.22% | +25.0% |
| Q3 2018 | $19,755,000 | +12.9% | 181,806 | +2.6% | 0.18% | 0.0% |
| Q2 2018 | $17,491,000 | +0.7% | 177,246 | -0.1% | 0.18% | -0.6% |
| Q1 2018 | $17,376,000 | +5.8% | 177,506 | +0.3% | 0.18% | +7.1% |
| Q4 2017 | $16,423,000 | +6.8% | 176,936 | -1.3% | 0.17% | -2.3% |
| Q3 2017 | $15,384,000 | -5.5% | 179,338 | -7.0% | 0.17% | -9.4% |
| Q2 2017 | $16,283,000 | -16.0% | 192,761 | -14.9% | 0.19% | -17.0% |
| Q1 2017 | $19,382,000 | +14.3% | 226,615 | +4.0% | 0.23% | +11.7% |
| Q4 2016 | $16,961,000 | -1.6% | 217,900 | -0.9% | 0.21% | -7.6% |
| Q3 2016 | $17,239,000 | -23.0% | 219,907 | -0.8% | 0.22% | -25.9% |
| Q2 2016 | $22,387,000 | +12.9% | 221,657 | +6.0% | 0.30% | +5.6% |
| Q1 2016 | $19,829,000 | +16.5% | 209,032 | +14.1% | 0.28% | +17.3% |
| Q4 2015 | $17,019,000 | +15.7% | 183,232 | +6.2% | 0.24% | +8.0% |
| Q3 2015 | $14,711,000 | -31.6% | 172,566 | -31.4% | 0.22% | -26.2% |
| Q2 2015 | $21,520,000 | -2.0% | 251,436 | -2.7% | 0.30% | +1.0% |
| Q1 2015 | $21,950,000 | -1.2% | 258,536 | -0.2% | 0.30% | -1.0% |
| Q4 2014 | $22,211,000 | +12.0% | 259,136 | -0.7% | 0.30% | +9.7% |
| Q3 2014 | $19,834,000 | -3.8% | 261,036 | -0.3% | 0.28% | -2.8% |
| Q2 2014 | $20,614,000 | +4.9% | 261,836 | -0.0% | 0.29% | +2.5% |
| Q1 2014 | $19,645,000 | -2.5% | 261,936 | +0.4% | 0.28% | -3.1% |
| Q4 2013 | $20,144,000 | +10.2% | 260,936 | -1.0% | 0.29% | +2.9% |
| Q3 2013 | $18,275,000 | +9.1% | 263,636 | -0.4% | 0.28% | +7.7% |
| Q2 2013 | $16,758,000 | – | 264,736 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |